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Purpose: Despite the fact that desflurane prolongs the QTC interval in humans, lit-
tle is known about the mechanisms that underlie these actions. We investigated the 
effects of desflurane on action potential (AP) duration and underlying electrophys-
iological mechanisms in rat ventricular myocytes. Materials and Methods: Rat 
ventricular myocytes were enzymatically isolated and studied at room tempera-
ture. AP was measured using a current clamp technique. The effects of 6% (0.78 
mM) and 12% (1.23 mM) desflurane on transient outward K+ current (Ito), sus-
tained outward current (Isus), inward rectifier K+ current (IKI), and L-type Ca2+ cur-
rent were determined using a whole cell voltage clamp. Results: Desflurane pro-
longed AP duration, while the amplitude and resting membrane potential remained 
unchanged. Desflurane at 0.78 mM and 1.23 mM significantly reduced the peak Ito 
by 20±8% and 32±7%, respectively, at +60 mV. Desflurane (1.23 mM) shifted the 
steady-state inactivation curve in a hyperpolarizing direction and accelerated inac-
tivation of the current. While desflurane (1.23 mM) had no effects on Isus and IKI, it 
reduced the L-type Ca2+ current by 40±6% (p<0.05). Conclusion: Clinically rele-
vant concentrations of desflurane appear to prolong AP duration by suppressing Ito 
in rat ventricular myocytes.
Key Words:   Desflurane, cardiac myocytes, action potential, transient outward K+ 
current, rat
INTRODUCTION
Desflurane has been reported to prolong the QTc interval in healthy adults1-3 and 
children4 during anesthesia induction. In guinea pig ventricular myocardium in vi-
tro,5 desflurane apparently prolonged the action potential (AP) duration by inhibit-
ing the slowly activating delayed outward K+ current.  
Cardiac AP duration is determined by balance between the inward and outward 
membrane currents.6,7 In most species, the transient outward K+ current (Ito) is re-
sponsible for the initial phase of repolarization, and the L-type Ca2+ current (ICa,L) 
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fusion was performed for 5 min with Kraftbrühe solution (10 
mM taurine, 10 mM oxalic acid, 70 mM glutamic acid, 35 
mM KCl, 10 mM H2PO4, 11 mM glucose, 0.5 mM EGTA, 
and 10 mM HEPES, pH 7.4). The ventricles were then cut 
off, minced with scissors, and agitated in a small beaker of 
Kraftbrühe solution. The resulting slurry was filtered through 
a 200-µm nylon mesh. The isolated ventricular cells were 
stored in Kraftbrühe solution for 1 hour at room temperature 
(21-22°C), then kept at 4°C, and used within a period of 8 
hours. Only rod-shaped cells with apparent striations that re-
mained quiescent in the solution containing 2 mM CaCl2 
were used for the experiments. The whole-cell voltage-clamp 
studies were performed at room temperature to enhance the 
viability of the isolated myocytes during recording.  
Fifty-seven ventricular cells from 30 rats were used in 
this study. Single cells were used in most experiments, but 
replicate experiments in single cells were carried out in part 
in IKI measurements. In nine cells used for measurement of 
IKI, we replicated measurement of IKI in six cells following 
measurements of Ito, because recovery of Ito following wash-
out was usually complete. We confirmed that the results of 
IKI between three single cells and six replicate cells were 
consistent with no alteration of IKI by desflurane.  
Electrophysiologic techniques  
Isolated myocytes were allowed to settle to the bottom of a 
recording chamber and mounted on an inverted microscope, 
where bathing solutions could be exchanged. The chamber 
was continuously perfused at a constant rate (2 mL/min). 
Standard whole-cell voltage-clamp methods were used.12 In 
order to establish a stable baseline, an interval of 4-6 min 
was allowed after initiating the whole-cell recording con-
figuration. Voltage-clamp measurements were performed 
using an Axopatch 200B patch clamp amplifier (Axon In-
struments Inc., Foster City, CA, USA). Patch electrodes were 
prepared from a borosilicate glass model KIMAX-51 (Amer-
ican Scientific, Charlotte, NC, USA) with a two-stage mi-
cropipette puller. The pipette tips were heat-polished, using 
a microforge, giving a typical resistance of 2-3 MΩ when 
filled with an internal solution. Data acquisition was per-
formed using a pCLAMP system version 6.0 (Axon Instru-
ments Inc., Foster city, CA, USA).  
Voltage-clamp protocols  
The APs were elicited in current-clamp mode by 5-ms, 
800-pA current injections at a frequency of 1 Hz.  
To examine the Ito, the cells were depolarized to -40 mV 
is the main inward current during the plateau phase. Near 
the end of the ventricular AP plateau, delayed outward K+ 
current (IK) activation initiates repolarization, and the inward 
rectifier K+ current (IKI) plays an important role in generat-
ing the resting membrane potential and modulating the final 
repolarization phase of ventricular AP.7  
The contributions of these currents vary between species 
and are responsible for characteristic differences in AP shape. 
For example, rat ventricular myocytes possess a prominent 
Ito, the major outward current of the repolarization phase 
but little IK, and have a short AP duration. In contrast, guin-
ea pig ventricular cells lack Ito, but have a slowly activating 
IK, resulting in a long-lasting AP.8 While the current density 
of Ito in human ventricular myocytes (8.2±0.7 pA/pF at +60 
mV) is two to three times smaller than that of rat myocytes, it 
is, nonetheless, a prominent K+ outward current in human 
atrial and ventricular tissue.9-11 Small changes in Ito during 
the early phase of AP can profoundly affect the activation of 
the other plateau currents, such as Ca2+ and IK, influencing 
AP duration. Although desflurane appears to inhibit the 
slowly activating IK and ICa,L in guinea pig ventricular myo-
cytes,5 the effects of desflurane on Ito have not been identi-
fied. We explored the effects of desflurane on Ito, IKI, and 
ICa,L in order to further elucidate the mechanisms of pro-
longing APs in rat ventricular myocytes. 
MATERIALS AND METHODS
　　　
The animal procedures conformed to a protocol approved 
by the Yonsei University College of Medicine Animal Re-
search Committee (Seoul, Korea).
Myocyte isolation
The rat hearts (Sprague-Dawley, weighing 250-300 g) were 
quickly excised following enflurane anesthesia and retro-
gradely perfused using a Langendorff perfusion system for 
5 min at 37°C. Perfusion was done at a rate of 7 mL/min 
with a modified Tyrode solution (143 mM NaCl, 5.4 mM 
KCl, 1.8 mM CaCl2, 0.5 mM MgCl2, 5 mM HEPES, and 
5.5 mM glucose, pH 7.4). The perfusate was then switched 
to a nominally Ca2+-free Tyrode solution for 5 min, followed 
by perfusion with the same solution containing collagenase 
(0.4 mg/mL, Worthington type II, Worthington Biochemical 
Corporation, Lakewood, NJ, USA) and hyaluronidase (0.4 
mg/mL, Sigma type II, Sigma-Aldrich Co., St. Louis, MO, 
USA). After a 10-12 min enzymatic treatment, a final per-
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crements, using a 200-ms pulse applied at 5-s intervals. 
Voltage-dependent ICa,L was evoked by step depolariza-
tion for 500 ms from a holding potential of -40 mV to +0 
mV in one step at a frequency of 0.1 Hz.
After baseline measurements, the myocytes were exposed 
to 6% or 12% desflurane for 2-3 min, and recovery responses 
were measured after washing for 2-3 min to remove the 
drug. Applying desflurane for 2 min produced a stable and 
consistent effect in the pilot experiments. 
Solutions and chemicals
Before establishing the whole-cell recording configuration, 
modified Tyrode solution (140 mM NaCl, 5.4 mM KCl, 1 
mM CaCl2, 1 mM MgCl2, 5 mM HEPES, 10 mM glucose, 
adjusted to pH 7.4 with 1 N NaOH) was used as an external 
bathing solution. For K+ current measurements, a patch pi-
pette solution (20 mM KCl, 110 mM K-aspartate, 10 mM 
EGTA, 10 mM HEPES, 1 mM MgCl2, 5 mM K2ATP, 1 mM 
CaCl2, 10 mM NaCl, adjusted to pH 7.2 with 3 N KOH) was 
used. To measure Isus, 5 mM 4-aminopyridine was added to 
the modified Tyrode solution and the pH corrected to 7.4 
with HCl. In order to eliminate any confounding Ca2+ current 
from the K+ current studies, 0.2 mM CdCl2 was added to 
the external solution after establishing the whole-cell volt-
age-clamp.
The inward Ca2+ current was measured using a patch pi-
pette solution (30 mM CsCl, 100 mM aspartic acid, 100 mM 
CsOH, 10 mM BAPTA, 10 mM HEPES, 10 mM phospho-
creatine, 1 mM Na2GTP, 5 mM Na2ATP, 10 mM glucose, 2 
mM MgCl2, adjusted to pH 7.2 with 1 M CsOH). Once whole-
cell recording was achieved, the bathing solution was ex-
changed for a solution containing 140 mM NaCl, 5.4 mM 
CsCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, adjusted 
to pH 7.4 with 1 M CsOH. Desflurane was purchased from 
the Baxter Healthcare Corporation (Deerfield, IL, USA). All 
other chemicals were purchased from Sigma-Aldrich Co.
Before perfusion, the external bathing solution was equil-
ibrated in a reservoir with desflurane, which was supplied 
by a gas dispersion tube connected to an outlet of the desflu-
rane vaporizer for 15 min. One hundred percent O2 (flow 
rate: 0.2 L/min) was passed through a desflurane vaporizer 
(Devapor Type M32600, Dräger AG, Lübeck, Germany). 
The end-tidal concentrations of desflurane were monitored 
using a calibrated gas analyzer (Capnomac, Datex, Helsinki, 
Finland). Six and 12% desflurane corresponded to 0.78±0.05 
mM (n=3) and 1.23±0.03 mM (n=3) respectively. Given a 
Tyrode solution/gas partition coefficient of 0.27 at 22°C,17 
for 50 ms from a holding potential of -80 mV to inactivate 
the Na+ current, then depolarized to test potentials up to +60 
mV in 10-mV increments for 300 ms. To obtain more infor-
mation about the possible mechanism of the desflurane-in-
duced voltage blockade of K+ currents, the voltage depen-
dence of steady-state inactivation was determined using a 
standard double-pulse protocol. The membrane potential 
was initially clamped at -80 mV and stepped to different 
potentials ranging from -100 to 0 mV in 10-mV increments 
for 500 ms followed by a 200-ms test pulse to +80 mV.  The 
voltage clamp protocol was repeated every 2 s. Steady state 
inactivation data were fitted to a Boltzmann distribution of 
the following equation: I/Imax=I/{1+exp [(V-V1/2)]/κ}, where 
Imax is the maximal current, V1/2 is the membrane potential 
producing 50% inactivation, and κ is the slope factor. 
To determine whether the acceleration of Ito inactivation 
in the presence of desflurane could be associated with time-
dependent closure of the open channels, the magnitude of 
current inhibition at various times after the initiation of the 
depolarizing pulse was determined at a membrane potential 
of +60 mV. The outward current in the presence of each des-
flurane concentration, normalized to the control outward cur-
rent, was plotted as a function of time after the start of de-
polarization. Because inactivation increases exponentially 
during depolarization, the equation [(Icontrol-Idrug)/Icontrol=a1× 
(1-e-t/τ)+a2] was used to describe the rate of inhibition of Ito at 
each desflurane concentration where τ is the time constant of 
inhibition development. (Icontrol-Idrug)/Icontrol equals the amount 
of inhibition at time t, a1 equals the maximum inhibition at a 
drug concentration, and a2 equals the zero intercept. The ex-
trapolation to “time zero” shows the proportion of channels 
inhibited before the start of the pulse, which is an indirect 
measure of the proportion of channels inhibited in the rest-
ing state.13 
The outward currents activated by depolarizing voltage 
steps in rat ventricular myocytes consist of a rapidly inacti-
vating component, Ito, and a non-inactivating, sustained com-
ponent, Isus.14,15 The sustained outward current (Isus) was re-
corded with the same voltage protocol after addition of 5 
mM 4-aminopyridine in a modified Tyrode solution, which 
preferentially blocks Ito. Isus in adult rat ventricular myocytes 
is responsible for the slower phase of AP repolarization back 
to the resting membrane potential.16 The Isus, comprised of 
IK and a small time-independent outward current,14 remain 
in the presence of 4-aminopyridine.  
IKI was measured following step depolarizations from -140 
to -40 mV from a holding potential of -40 mV in 20 mV in-
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amplitude and resting membrane potential remained unal-
tered (Table 1). AP duration returned to the baseline follow-
ing washout. 
Transient outward K+ current
At +60 mV, 0.78 mM desflurane reduced the control peak 
currents of Ito (3.17±0.86 nA) by 20±8% in 10 cells (p<0.05), 
and the plateau currents measured at the end of depolariza-
tion [1.12 (0.92-1.35) nA] by 9% (8.8-9.6%) (p<0.05). Des-
flurane 1.23 mM reduced the control peak currents of Ito 
(3.27±1.03 nA) by 32±7% in 10 cells (p<0.05) and the pla-
teau currents (1.37±0.32 nA)] by 13±14% (p<0.05) (Fig. 
2). Both peak and plateau currents were completely recov-
the aforementioned desflurane concentrations are equivalent 
to gas phase concentrations of 7.0% and 11.0%, respectively.  
Statistical analysis
One-way repeated measures of ANOVA followed by the 
Student-Newman-Keuls test were applied to test for signifi-
cant differences among the control, drug application, and 
washout. Unpaired t-tests were used to compare differences 
in Ito currents between 6% and 12% desflurane. All values 
are expressed as mean±SD. A p value of less than 0.05 was 
considered significant. In the case of results that were not 
normally distributed, ANOVA of ranks was used, followed 
by the Student-Newman-Keuls test. In this case, results are 
expressed as median (IQR). Statistical comparisons were 
conducted with Sigmastat (SPSS Inc., Chicago, IL, USA) 
and all figures were prepared using Origin (Microcal Soft-
ware Inc., Northampton, MA, USA).
 
RESULTS
Normal action potential
Fig. 1 shows the concentration-dependent prolongation of 
AP in a rat ventricular myocyte. APD50 and APD90 was pro-
longed by 42±26% (p<0.05) and 21±13% (p<0.05), respec-
tively, in the presence of 1.23 mM desflurane in 10 cells. AP 
Fig. 1. Effect of desflurane (DES) on action potential duration in a rat ven-
tricular myocyte. C, control.
Fig. 2. Effects of desflurane (DES) on transient outward K+ current (Ito) in rat ventricular myocytes. (A) Recordings of control, 1.23 mM DES, 
and recovery in rat ventricular myocytes. Closed and open circles indicate the peak current of Ito at every potential in the control and 1.23 
mM DES. Triangles represent the plateau currents at the end of the test pulses before (closed) and after (open) applying of 1.23 mM DES. 
Squares represent the peak (closed) and plateau (open) currents after wash. The currents shown are for depolarization from -40 to +60 
mV in 10 mV steps. (B) Current-voltage relations of Ito in 10 cells. Closed and open circles indicate the peak current of Ito at every potential 
in the control and 1.23 mM DES. Triangles represent the plateau currents at the end of the test pulses before (closed) and after (open) ap-
plication of 1.23 mM DES. (C) Effects of 0.78 mM and 1.23 mM DES on the amplitude of the peak Ito at +60 mV in 10 cells.  *p<0.05 versus 
control. †p<0.05 versus 0.78 mM DES. Error bars indicate mean±SD.
Table 1. Effects of Desflurane (1.23 mM) on Action Potential Characteristics in Isolated Rat Ventricular Myocytes
RMP, mV AMP, mV APD50, ms APD90, ms
Control -70±2 139±6   5±2  17±4
Desflurane -70±2   134±13      8±3*    20±6*
Washout -70±2   138±11   5±1  16±4
RMP, resting membrane potential; AMP, action potential amplitude; APD50, action potential duration measured at 50% of repolarization; 
APD90, action potential duration measured at 90% of repolarization.
Values represent mean±SD. n=10 cells. 
*p<0.05, different from control and washout values.
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κ=9.95±0.8) (Fig. 3).  
Fig. 2A shows that desflurane accelerates decay of the 
current during the pulse, so we evaluated the effect of des-
flurane on Ito inactivation kinetics. Individual current re-
cords, evoked by a test pulse to +60 mV, were fitted to an ex-
ponential function. Unlike the control currents in which the 
decay could be fitted by a single exponential, inactivation 
of Ito in the presence of desflurane was better described by a 
double exponential. Fig. 4A and B show the quality of fit of 
the single and double exponential functions to the inactiva-
tion phase of Ito under the control and 1.23 mM desflurane 
conditions. The control τ1 (26±10 ms) was reduced to 9±4 
ms by 1.23 mM desflurane in 7 cells (p<0.05). Inactivation 
kinetics returned to baseline values following washout (24±8 
ms) (Fig. 4C).
Fig. 5 shows inhibition of Ito between the control and in 
the presence of 0.78 mM and 1.23 mM desflurane during 
the first 60 ms of depolarization. Inhibition induced by des-
flurane was an exponential function of time. Both the magni-
tude of the maximum inhibition and its rate of development 
appeared to be concentration-dependent. The maximum 
amount of inhibition by 0.78 mM and 1.23 mM desflurane 
were 0.58±0.11 and 0.82±0.09 in 8 cells, respectively. The 
ered after wash. 
Under control conditions, the voltage required for half-in-
activation (V1/2) and slope factor (κ) for Ito were -29.3±0.6 
mV and 7.8±0.5 mV, respectively, in 10 cells. Desflurane 
1.23 mM significantly shifted the steady-state inactivation 
curve in a hyperpolarizing direction (V1/2=-34.3±0.9 mV, 
Fig. 3. Steady state inactivation curves of transient outward K+ currents under control conditions and 1.23 mM desflurane (DES). Closed 
and open circles indicate control and 1.23 mM DES, respectively. Data are presented as mean±SD for 10 cells and were fitted with the 
Boltzman function. The half inactivations (V1/2) of the control and 1.23 mM DES were -29.3±0.6 mV and -34.3±0.9 mV, respectively. 
Fig. 4. Effect of desflurane (DES) on current inactivation. The inactivation phase of transient outward K+ current (Ito) were best fitted by 
single and double exponential functions under control conditions (A) and 1.23 mM DES (B), respectively, in a rat ventricular myocyte. 
Mean values of τ1 in 7 cells under control conditions, 1.23 mM DES, and after washout (C). *p<0.05 versus control and recovery. Error bars 
indicate mean±SD.
Fig. 5. Time-dependent inhibition of transient outward K+ currents (Ito) by 
desflurane. Time course of the development of inhibition by 0.78 mM and 
1.23 mM desflurane in each of the 8 cells during a depolarizing pulse to +60 
mV from a holding potential of -40 mV. The reduction of Ito in the presence 
of desflurane is expressed as a proportion of the control current at any giv-
en time after the start of the depolarizing pulse. 
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1.23 mM desflurane did not alter IKI in nine cells (Fig. 7). IKI 
was measured at the end of the pulse duration. Prior to des-
flurane exposure, the baseline values during test potential of 
-140 mV were -2.52±0.73 nA.
L-type Ca2+ current 
At +10 mV, 1.23 mM desflurane reduced the ICa,L by 40±6% 
in 8 cells (p<0.05) (Fig. 8). The effects of desflurane on ICa,L 
were completely reversed following washout. The baseline 
values before exposure to 1.23 mM desflurane were -2.24± 
0.83 nA. 
time constants for the increased decline in current were 
32±13 ms and 12±7 ms, respectively, for 0.78 mM and 1.23 
mM desflurane.
Sustained outward current
Desflurane (1.23 mM) had no effect on Isus (Fig. 6). Before 
desflurane exposure, the baseline Isus values at the end of 
the plateau at +60 mV were 1.12±0.24 nA in six cells. 
Inward rectifier K+ current
At membrane potential ranging from -140 mV to -40 mV, 
Fig. 6. The effects of desflurane (DES) on sustained outward currents (Isus) in a rat ventricular myocyte. (A) A control recording of tran-
sient outward K+ currents (Ito). (B) Isus obtained after application of 5 mM 4-aminopyridine (4-AP), which preferentially blocks Ito. (C) 1.23 
mM DES exposure after application of 5 mM 4-aminopyridine.
Fig. 7. Effect of desflurane (DES) on the inward rectifier K+ current (IKI) in rat ventricular myocytes. (A) Closed and open circles indicate 
control and 1.23 mM DES in a rat ventricular myocyte, respectively, at a membrane potential of -140 mV. The dotted line indicates recov-
ery after wash. (B) Current-voltage relations for IKI before and after applying 1.23 mM DES in 9 cells. Closed and open circles indicate con-
trol and 1.23 mM DES, respectively. Error bars indicate mean±SD.
Fig. 8. Effect of desflurane (DES) on L-type Ca2+ current (ICa,L).  (A) A representative example of the effect of DES on ICa,L in a rat ventricular 
myocyte. The open circles represent the peak of an individual current record. The horizontal bar indicates the period of DES application. (B) 
An example of individual currents recorded in the presence of 1.23 mM DES. Closed and open circles indicate control and 1.23 mM DES, re-
spectively. The dotted line indicates recovery after wash.  
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of the gate, or might represent desflurane binding and block-
ade of the open channel that follows an exponential time 
course during continued depolarization. Nevertheless, the 
extrapolation to time zero shows that desflurane does not 
significantly inhibit Ito before its activation at the onset of 
depolarization. The hyperpolarizing shift of the inactivation 
curve indicates that desflurane does depress Ito in part by re-
ducing the availability of Ito channels.
Isus contributes to the overall repolarization process in rat 
ventricular myocytes. In the present study, Isus was not af-
fected by desflurane, whereas desflurane 1.23 mM signifi-
cantly depressed IK in guinea pig ventricular cells, by ap-
proximately 40%.5 Although IK suppression by desflurane 
in guinea pig ventricular myocytes is mainly responsible for 
AP prolongation,5 Isus is not likely to contribute to prolonga-
tion of AP duration by desflurane in rat ventricular myocytes. 
Presumably, the subtle change in Isus by desflurane may be 
attributed to relative variations of Ito and IK (Ito/IK) among 
rat ventricular cells,16 significant inhibition of IK by 4-ami-
nopyridine at concentrations above 1 mM,14 and/or species 
differences.
The IKI is the primary current that maintains stable cardi-
ac resting membrane potential near the K+ equilibrium po-
tential. Thus, inhibition of IKI can result in diastolic depolar-
ization, which can increase cardiac excitability28 and lead to 
dysarrythmias and abnormal automaticity.29 In our results, 
desflurane did not alter the inward component of IKI, similar 
to the modest effects on inward and outward components of 
IKI by desflurane in guinea pig ventricular myocytes.5 The 
lack of change in the resting membrane potential by desflu-
rane in our results may reflect the lack of effect on IKI. In 
the present study at steady state inactivation, approximately 
80% of the Ito channels appeared to be available for activa-
tion at -40 mV. This indicates that the outward component 
of IKI above -40 mV includes Ito so that the outward compo-
nent of IKI above -40 mV can be influenced by Ito in this 
preparation.   
Even with a prolonged AP duration, our whole-cell volt-
age-clamp studies revealed a reduction of peak ICa,L. Indi-
rect evidence for inhibition of Ca2+ entry by desflurane has 
been proposed in rat isolated myocardial preparations,30 and 
suppression of ICa,L by desflurane has been reported in guin-
ea pig ventricular myocytes.5 Inhibition of ICa,L would short-
en AP duration, but reduction of Ito appears to have a great-
er effect, resulting in lengthening of AP duration. 
In human ventricular myocytes, although the current den-
sity of Ito (8.2±0.7 pA/pF at +60 mV) has been reported to 
DISCUSSION
Our results showed that clinically relevant desflurane con-
centrations prolonged AP duration in isolated rat ventricular 
myocytes and significantly inhibited Ito and ICa,L. Desflurane 
significantly accelerated current inactivation of Ito and shifted 
the steady-state inactivation curve.
Desflurane prolongs ventricular AP duration in guinea 
pigs,5 which supports our results in rats. Considering that the 
QT interval is in accordance with AP duration in the ventric-
ular myocardium, the prolonged AP duration in guinea pig5 
and rat ventricular myocytes in our results may support clini-
cal evidence of a prolonged QTc interval in healthy adults1-3 
and children4 during induction of anesthesia with desflurane. 
In rat ventricular myocytes, the cardiac voltage-activated 
K+ current consists of Ito, which is sensitive to 4-aminopyri-
dine, and IK, which is sensitive to tetraethylammonium.16 IK is 
the prominent voltage-activated outward K+ current in frog18 
and guinea pig ventricular myocytes.19 However, in rat,20 
dog,21 rabbit,22 and human myocytes,10 Ito is prominent and 
plays a significant role in the repolarization phase, particu-
larly in the early phase of AP. In several cardiac tissues, two 
types of Ito have been identified; one is voltage- and Ca2+-in 
dependent, and the other is Ca2+ -dependent.23,24 In rat ven-
tricular myocytes, only Ca2+-independent Ito has been iden-
tified.25 The Ca2+-independent Ito carried predominantly by 
K+ ions has been suggested to be a major determinant of 
cardiac AP duration because of its size and pronounced fre-
quency dependence.24 
Prolonged AP duration caused by inhibition of Ito has been 
demonstrated with tedisamil, an Ito and IK blocker in mam-
malian cardiac cells, in isolated rat ventricular myocytes26 
and in rat papillary muscles.27 The reduction of Ito by ap-
proximately 20% by 0.78 mM desflurane appears to be a 
fractional reduction of the current. However, considering 
the large current density of Ito in rat ventricular myocytes, 
19.9±2.8 pA/pF at +60 mV,9 desflurane would have a great-
er effect on the AP plateau phase, prolonging AP.
The results of the present study show that desflurane not 
only decreased the peak Ito but also accelerated the current 
decay during a sustained depolarization. With sustained de-
polarization, there was an apparent anesthetic-induced ac-
celeration of the current inactivation that followed an expo-
nential time course. This channel inhibition could be due to 
an acceleration of the inactivation process involving the 
channel molecular rearrangement to accelerate the closing 
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8. Rees S, Curtis MJ. Which cardiac potassium channel subtype is 
the preferable target for suppression of ventricular arrhythmias? 
Pharmacol Ther 1996;69:199-217.
9. Wettwer E, Amos G, Gath J, Zerkowski HR, Reidemeister JC, 
Ravens U. Transient outward current in human and rat ventricular 
myocytes. Cardiovasc Res 1993;27:1662-9.
10. Näbauer M, Beuckelmann DJ, Erdmann E. Characteristics of tran-
sient outward current in human ventricular myocytes from patients 
with terminal heart failure. Circ Res 1993;73:386-94.
11. Nánási PP, Varró A, Lathrop DA. Ionic currents in ventricular my-
ocytes isolated from the heart of a patient with idiopathic cardio-
myopathy. Cardioscience 1992;3:85-9.
12. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Im-
proved patch-clamp techniques for high-resolution current record-
ing from cells and cell-free membrane patches. Pflugers Arch 
1981;391:85-100.
13. Castle NA. Bupivacaine inhibits the transient outward K+ current 
but not the inward rectifier in rat ventricular myocytes. J Pharma-
col Exp Ther 1990;255:1038-46.
14. Slawsky MT, Castle NA. K+ channel blocking actions of fle-
cainide compared with those of propafenone and quinidine in 
adult rat ventricular myocytes. J Pharmacol Exp Ther 1994;269: 
66-74.
15. He J, Kargacin ME, Kargacin GJ, Ward CA. Tamoxifen inhibits 
Na+ and K+ currents in rat ventricular myocytes. Am J Physiol 
2003;285:H661-8.
16. Apkon M, Nerbonne JM. Characterization of two distinct depolar-
ization-activated K+ currents in isolated adult rat ventricular myo-
cytes. J Gen Physiol 1991;97:973-1011.
17. Hönemann CW, Washington J, Hönemann MC, Nietgen GW, Du-
rieux ME. Partition coefficients of volatile anesthetics in aqueous 
electrolyte solutions at various temperatures. Anesthesiology 
1998;89:1032-5.
18. Hume JR, Giles W. Ionic currents in single isolated bullfrog atrial 
cells. J Gen Physiol 1983;81:153-94.
19. Hume JR, Uehara A. Ionic basis of the different action potential 
configurations of single guinea-pig atrial and ventricular myo-
cytes. J Physiol 1985;368:525-44.
20. Josephson IR, Sanchez-Chapula J, Brown AM. Early outward 
current in rat single ventricular cells. Circ Res 1984;54:157-62.
21. Litovsky SH, Antzelevitch C. Transient outward current promi-
nent in canine ventricular epicardium but not endocardium. Circ 
Res 1988;62:116-26.
22. Giles W, Shimoni Y. Comparison of sodium-calcium exchanger 
and transient inward currents in single cells from rabbit ventricle. 
J Physiol 1989;417:465-81.
23. Coraboeuf E, Carmeliet E. Existence of two transient outward 
currents in sheep cardiac Purkinje fibers. Pflugers Arch 1982;392: 
352-9.
24. Escande D, Coulombe A, Faivre JF, Deroubaix E, Coraboeuf E. 
Two types of transient outward currents in adult human atrial cells. 
Am J Physiol 1987;252:H142-8.
25. Dukes ID, Morad M. The transient K+ current in rat ventricular 
myocytes: evaluation of its Ca2+ and Na+ dependence. J Physiol 
1991;435:395-420.
26. Dukes ID, Cleemann L, Morad M. Tedisamil blocks the transient 
and delayed rectifier K+ currents in mammalian cardiac and glial 
cells. J Pharmacol Exp Ther 1990;254:560-9.
27. Walker MJ, Beatch GN. Electrically induced arrhythmias in the 
rat. Proc West Pharmacol Soc 1988;31:167-70.
be two or three times smaller than that of rat myocytes, it is, 
nonetheless, a major outward current.9-11 Small changes in 
Ito during the early phase of AP in human ventricular myo-
cytes can profoundly affect activation of other plateau cur-
rents, such as Ca2+ and delayed outward K+ currents, influ-
encing both AP duration and Ca2+ influx. The overall results 
of this study demonstrate that, at equivalent anesthetic con-
centrations, the actions of desflurane are almost identical to 
sevoflurane.31 The similarity in these basic electrophysio-
logical effects is paralleled by the similarity in clinically ob-
served changes.1-3 
In conclusion, clinically relevant desflurane concentra-
tions appear to prolong AP duration in rat ventricular myo-
cytes by suppressing Ito. Considering the similar voltage- 
and time-dependence of Ito between human and rat heart 
cells,9 desflurane suppression of Ito may partially account 
for clinical observations of QTc prolongation in humans. 
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